| Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan SC Yang, WW Lai, CC Lin, WC Su, LJ Ku, JS Hwang, JD Wang Lung Cancer 108, 183-191, 2017 | 63 | 2017 |
| Liquid biopsy genotyping in lung cancer: ready for clinical utility? WL Huang, YL Chen, SC Yang, CL Ho, F Wei, DT Wong, WC Su, CC Lin Oncotarget 8 (11), 18590, 2017 | 59 | 2017 |
| Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer PL Su, YL Wu, WY Chang, CL Ho, YL Tseng, WW Lai, WC Su, CC Lin, ... Therapeutic Advances in Medical Oncology 10, 1758835918797589, 2018 | 46 | 2018 |
| Rasch models suggested the satisfactory psychometric properties of the World Health Organization Quality of Life—Brief among lung cancer patients CY Lin, SC Yang, WW Lai, WC Su, JD Wang Journal of health psychology 22 (4), 397-408, 2017 | 44 | 2017 |
| The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis WY Chang, YL Wu, PL Su, SC Yang, CC Lin, WC Su PloS one 13 (2), e0192161, 2018 | 41 | 2018 |
| Estimating the lifelong health impact and financial burdens of different types of lung cancer SC Yang, WW Lai, WC Su, SY Wu, HHW Chen, YL Wu, MC Hung, ... BMC cancer 13, 1-9, 2013 | 29 | 2013 |
| Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in … CZ Chen, CY Ou, CH Yu, SC Yang, HY Chang, TR Hsiue Journal of the American Geriatrics Society 63 (2), 244-250, 2015 | 21 | 2015 |
| Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: an interrupted time series study JC Hsu, CF Wei, SC Yang, PC Lin, YC Lee, CY Lu BMJ open 10 (5), e033427, 2020 | 20 | 2020 |
| Dynamic changes of health utility in lung cancer patients receiving different treatments: a 7-year follow-up SC Yang, CW Kuo, WW Lai, CC Lin, WC Su, SM Chang, JD Wang Journal of Thoracic Oncology 14 (11), 1892-1900, 2019 | 20 | 2019 |
| Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer SC Yang, CC Lin, WW Lai, SM Chang, JS Hwang, WC Su, JD Wang Therapeutic advances in medical oncology 10, 1758834018755072, 2018 | 20 | 2018 |
| Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: adjusting quality-of-life and lead-time bias for utility … SC Yang, WW Lai, HY Chang, WC Su, HHW Chen, JD Wang Lung Cancer 86 (1), 96-101, 2014 | 19 | 2014 |
| Health-related quality of life after first-line anti-cancer treatments for advanced non-small cell lung cancer in clinical practice SC Yang, WW Lai, TR Hsiue, WC Su, CK Lin, JS Hwang, JD Wang Quality of Life Research 25, 1441-1449, 2016 | 18 | 2016 |
| Positive blood culture is not associated with increased mortality in patients with sepsis‐induced acute respiratory distress syndrome SC Yang, KM Liao, CW Chen, WC Lin Respirology 18 (8), 1210-1216, 2013 | 15 | 2013 |
| Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatment PL Su, SC Yang, YL Chen, YL Wu, CY Lin, WY Chang, YL Tseng, WW Lai, ... Cancer medicine 8 (13), 5939-5947, 2019 | 12 | 2019 |
| Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study JC Hsu, CF Wei, SC Yang BMJ open 9 (3), e022293, 2019 | 12 | 2019 |
| Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data SC Yang, JD Wang, SY Wang Scientific reports 11 (1), 12180, 2021 | 11 | 2021 |
| Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: analysis of real-world data in a tertiary hospital in Taiwan SC Yang, WW Lai, JC Hsu, WC Su, JD Wang PLoS One 15 (4), e0231413, 2020 | 11 | 2020 |
| EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis JS Tsai, PL Su, SC Yang, CC Chang, CY Lin, YT Yen, YL Tseng, WW Lai, ... Journal of the Formosan Medical Association 120 (9), 1729-1739, 2021 | 10 | 2021 |
| Cost-effectiveness of nivolumab plus ipilimumab with and without chemotherapy for advanced non-small cell lung cancer SC Yang, N Kunst, CP Gross, JD Wang, WC Su, SY Wang Frontiers in oncology 11, 760686, 2021 | 9 | 2021 |
| The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy PL Su, JY Chen, CY Chu, YL Chen, WL Chen, KY Lin, CL Ho, JS Tsai, ... Scientific reports 12 (1), 3319, 2022 | 8 | 2022 |
